# Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/combined-evaluation-of-lc3b-puncta-and-hmgb1-expression-predicts-residual-risk/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sylvain Ladoire,Frédérique Penault‐Llorca,Laura Senovilla,Cécile Dalban,David Enot,Clara Locher,Nicole Prada,Vichnou Poirier-Colame,Kariman Chaba,Laurent Arnould,François Ghiringhelli,P. Fumoleau,M. Spielmann,Suzette Delaloge,Marie Laure Poillot,Patrick Arveux,Aïcha Goubar,Fabrice André,Laurence Zitvogel,Guido Kroemer |
| Citations | 103 |
| DOI | 10.1080/15548627.2015.1082022 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/15548627.2015.1082022?needAccess=true&role=button |
| OpenAlex ID | https://openalex.org/W1889406201 |
| PMID | 26506894 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Aïcha Goubar](https://scholariq.org/researchers/aicha-goubar/)

## Paper primary topic

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

## Paper topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)
- [Advanced Glycation End Products research](https://scholariq.org/topics/advanced-glycation-end-products-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.